NOREPINEPHRINE in 5% Dextrose Injection, 8 mg per 250 mL (32 mg per mL) Injection, Rx only, SterR...
FDA Recall #D-0314-2022 — Class II — November 12, 2021
Product Description
NOREPINEPHRINE in 5% Dextrose Injection, 8 mg per 250 mL (32 mg per mL) Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-476-01.
Reason for Recall
Lack of Assurance of Sterility
Recalling Firm
SterRx, LLC — Plattsburgh, NY
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
1428 bags
Distribution
U.S.A. Nationwide
Code Information
S21409/CCR
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated